InvestorsHub Logo
Followers 118
Posts 5283
Boards Moderated 1
Alias Born 02/11/2013

Re: Brakeman post# 36747

Monday, 03/30/2015 11:48:30 PM

Monday, March 30, 2015 11:48:30 PM

Post# of 38376
I love the intrigue here. I am in this heavy as Dr Koos is in heavy. I am patient. Something comes soon imo glta ENTB. Meanwhile me, the longs, Dr. Koos, and the scientists are loaded up. $$$$ENTB$$$$

Based on 2,405,570, 642 shares issued and outstanding as of November 21, 2014


Title of Class Name and Address of Beneficial Owner
Amount and Nature
of Beneficial Owner
Percent of Class
Common
David R. Koos*
C/o Entest Bio Medical Inc., Inc
4700 SPRING STREET, SUITE 203, LA MESA, CALIFORNIA, 91942
75,000,000 3.1%

Common All Officers and Directors As a Group 75,000,000 3.1%

*Includes 10,000,000 common shares owned by Bio-Matrix Scientific Group, Inc. (David Koos is CEO, President and Chairman of Bio-Matrix Scientific Group, Inc.).
.
Based on 4,201,397 shares issued and outstanding as of November 21, 2014
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.